Tech Company Financing Transactions
MedCrypt Funding Round
MedCrypt secured a $36.4 million Series B funding round on 1/24/2023. Investors included Dexcom.
Transaction Overview
Company Name
Announced On
1/24/2023
Transaction Type
Venture Equity
Amount
$36,400,000
Round
Series B
Investors
Dexcom (Lead Investor)
Proceeds Purpose
These funds will be used to grow MedCrypt's engineering team in response to an increased demand for encryption and PKI solutions optimized for medical devices.
Company Information
Company Status
Private & Independent
Industry
Security
Mailing Address
1302 Coast Hwy. North 101 102
Encinitas, CA 92024
USA
Encinitas, CA 92024
USA
Phone
Undisclosed
Website
Email Address
Overview
MedEncrypt is one of the trusted leading nationwide providers of web-based dictation and transcription solutions. Our mission is to provide easy-to-use dictation and transcription applications which will enhance the quality of services offered at the most affordable pricing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Kijewski
Chief Scientific Officer
Brett Hemenway
Chief Technical Officer
Eric Pancoast
Browse more venture capital transactions:
Prev: 1/24/2023: Hatchfi venture capital transaction
Next: 1/24/2023: Zift Solutions venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs